Fatty Acid Profile of Postmenopausal Women Receiving, and Not Receiving, Hormone Replacement Therapy

Anna Maria Cybulska, Karolina Skonieczna-Żydecka, Arleta Drozd, Kamila Rachubińska, Jolanta Pawlik, Ewa Stachowska, Anna Jurczak and Elżbieta Grochans
Additional contact information
Anna Maria Cybulska: Department of Nursing, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland
Karolina Skonieczna-Żydecka: Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland
Arleta Drozd: Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland
Kamila Rachubińska: Student Research Association, Department of Nursing, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland
Jolanta Pawlik: Institut für Nephrologie und Dialyse Salem-Spital, Hirslanden Bern AG, 3000 Bern, Switzerland
Ewa Stachowska: Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland
Anna Jurczak: Department of Specialized Nursing, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland
Elżbieta Grochans: Department of Nursing, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland

IJERPH, 2019, vol. 16, issue 21, 1-15

Abstract: Menopause, the permanent cessation of the menstrual cycle, marks the end of a woman’s reproductive lifespan. Menopausal hormonal therapy (MHT) can potentially skew the fatty acid profile increasing the risk for developing metabolic diseases and disorders of skeletal, gastrointestinal, and nervous systems. The aim of this study was to investigate the fatty acid profile of postmenopausal women receiving, and not receiving, hormone replacement therapy. A total of 156 healthy women with a mean age of 60 participated in this cross-sectional study. Gas chromatography with an Agilent Technologies 7890A GC system was used to determine fatty acid content. Statistical analysis was conducted using R software, version 3.4.1. Women receiving MHT had significantly higher ( p < 0.05) concentrations of C14:0 and C16:0. MHT was found to be associated with a tendency ( p = 0.053) to diminish concentrations of C18:1n-9, C20:4, and all unsaturated fatty acids ( p < 0.05). The longer MHT was used, the higher the concentration of C24:1 ( p = 0.04) and the lower the concentration of C18:2n-6 ( p = 0.03).

Keywords: menopause; menopausal hormonal therapy; fatty acid (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/16/21/4273/pdf (application/pdf)
https://www.mdpi.com/1660-4601/16/21/4273/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:16:y:2019:i:21:p:4273-:d:283268

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().